Logo NANOPILOT PROJECT

Objectives based on industrial needs

Small GMP batches for clinical trials

Flexibility and adaptability

Regulatory compliance

The pilot plant will provide the small quantities of products that technology developers will require for full preclinical and first clinical validation.

Achieving a compromise between specialization, flexibility and economic viability.

Specialized pilot plant

  • Highly advances characterization techniques.
  • Polymeric nanopharmaceuticals.
  • Microreactors.

Flexibility & Adaptability

  • Campaign design.
  • Custom manufacturing.

The big pharma will require technology which is robust and translatable, that has completed full toxicological preclinical phase and had been validated in first clinical trials. That technology must fulfill strict regulatory requirements.